Skip to main content
RT @bella_mehta: How many new Adult Onset Still's Disease patients have you seen in the past year? @RheumNow #ACR20

Bella Mehta bella_mehta

5 years 11 months ago

How many new Adult Onset Still's Disease patients have you seen in the past year? @RheumNow #ACR20

RT @KDAO2011: #knowledgebowl #acr20
This DMARD can cause scleroderma renal crisis @RheumNow

k dao KDAO2011

5 years 11 months ago
#knowledgebowl #acr20 This DMARD can cause scleroderma renal crisis @RheumNow
RT @uptoTate: When do you tend to change tx strategies in PsA? #ACR20 @RheumNow

Dr. Rachel Tate uptoTate

5 years 11 months ago

When do you tend to change tx strategies in PsA? #ACR20 @RheumNow

Pipeline Therapies for Urate Lowering: Dr. Michael Pillinger

Dr. Pillinger reviews abstract #0675 and #0690 presented at the 2020 ACR annual meeting. 

 

 

How COVID Changed Work: Drs. Rachel Tate, Cassie Calabrese and Mary Hinojos Mamut

Dr. Rachel Tate, Dr. Cassie Calabrese and Dr. Mary Hinojos Mamut discuss how COVID has changed patient care, work-life balance, adapting and triaging opportunities and activities, and more. 

Measuring Disease Activity in Psoriatic Arthritis: Dr. Eric Ruderman

Dr. Ruderman looks at abstracts #0884, #0323 and #0909, which focus on disease activity measurement in psoriatic arthritis.

RT @uptoTate: When discussing pregnancy outcomes with your axSpA patients, do you address potential outcomes related to

Dr. Rachel Tate uptoTate

5 years 11 months ago
When discussing pregnancy outcomes with your axSpA patients, do you address potential outcomes related to disease in addition to medication concerns? #ACR20 @RheumNow
RT @lihi_eder: Despite 30% decrease in mortality over the past 2 decades, the mortality gap remains in psoriasis and #Ps

Lihi Eder lihi_eder

5 years 11 months ago
Despite 30% decrease in mortality over the past 2 decades, the mortality gap remains in psoriasis and #PsA. #ACR20 Abstract #1476 by @Keith_Colaco. @NPF @WCRInstitute @researchuoft @RheumNow @rheum_cat https://t.co/CXTELMJh8P
Prothrombotic Antiphospholipid Antibodies in COVID-19: Dr. David Liew

Dr. David Liew reviews abstract #0429 at the 2020 ACR annual meeting.

New Treatments in Axial Spondyloarthritis: Dr. Antoni Chan

 

Dr. Antoni Chan discusses abstracts #0369 and #0886 presented at the 2020 ACR annual meeting.

European Rheum Consortium (SHARE) recommendations for Rx of systemic JIA: 1) Systemic JIA - AOSD; 2) STEROIDs, 3) IL-1 i

Dr. John Cush RheumNow

5 years 11 months ago

European Rheum Consortium (SHARE) recommendations for Rx of systemic JIA: 1) Systemic JIA - AOSD; 2) STEROIDs, 3) IL-1 inhibitors; 4) TCZ, 5) MTX & TNFi mainly for arthritis. Should be aware of risk for MAS and ILD #ACR20 Abstr#1148 https://t.co/mgZvLKNljs

Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway

Dr. Conway discusses ACR abstract #1445 presented Sunday at the ACR annual meeting.

Recognition and Early Treatment of MAS: Dr Olga Petryna

Dr. Olga Petryna discusses two abstracts, abstract #1496 and #1149, presented at the ACR annual meeting. Abstracts available at www.acrabstracts.org.

×